Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Pharma Rxstrategy Yugian Liu Andy Killpack Specialty Clinical Solutions Us Clinical Development Kite Pharmaceuticals
Source: ajmc.com